IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

NeuroImmunoModulation

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

2.19

h-Index

2024-2025

 76

Rank

2024-2025

 8801

SJR

2024-2025

 0.653

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title NeuroImmunoModulation
Abbreviation NeuroImmunoModulation
Publication Type Journal
Subject Area, Categories, Scope Endocrine and Autonomic Systems (Q3); Endocrinology (Q3); Immunology (Q3); Neurology (Q3)
h-index 76
Overall Rank/Ranking 8801
SCImago Journal Rank (SJR) 0.653
Impact Score 2.19
Publisher S. Karger AG
Country Switzerland
ISSN 14230216, 10217401
Best Quartile Q3
Coverage History 1994-2002, 2004-2025




Aim and Scope


The rapidly expanding area of research known as neuroimmunomodulation explores the way in which the nervous system interacts with the immune system via neural, hormonal, and paracrine actions. Encompassing both basic and clinical research, "Neuroimmunomodulation" reports on all aspects of these interactions. Basic investigations consider all neural and humoral networks from molecular genetics through cell regulation to integrative systems of the body. The journal also aims to clarify the basic mechanisms involved in the pathogenesis of the CNS pathology in AIDS patients and in various neurodegenerative diseases. Although primarily devoted to research articles, timely reviews are published on a regular basis.


About NeuroImmunoModulation


NeuroImmunoModulation is a journal covering the technologies/fields/categories related to Endocrine and Autonomic Systems (Q3); Endocrinology (Q3); Immunology (Q3); Neurology (Q3). It is published by S. Karger AG. The overall rank of NeuroImmunoModulation is 8801. According to SCImago Journal Rank (SJR), this journal is ranked 0.653. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 76. The best quartile for this journal is Q3.

The ISSN of NeuroImmunoModulation journal is 14230216, 10217401. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. NeuroImmunoModulation is cited by a total of 319 articles during the last 3 years (Preceding 2024).


NeuroImmunoModulation Impact IF 2024-2025


The Impact IF 2024 of NeuroImmunoModulation is 2.19, which is computed in 2025 as per its definition. NeuroImmunoModulation IF is decreased by a factor of 0.19 and approximate percentage change is -7.98% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

NeuroImmunoModulation Impact IF 2025 Prediction


Impact IF 2024 of NeuroImmunoModulation is 2.19. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of NeuroImmunoModulation. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 2.19
2023 2.38
2022 2.53
2021 3.06
2020 2.47
2019 1.56
2018 1.77
2017 1.84
2016 3.18
2015 2.31
2014 2.12

NeuroImmunoModulation h-index


  Table Setting

NeuroImmunoModulation has an h-index of 76. It means 76 articles of this journal have more than 76 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




NeuroImmunoModulation ISSN


The ISSN of NeuroImmunoModulation is 14230216, 10217401. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

NeuroImmunoModulation Rank and SCImago Journal Rank (SJR)


The overall rank of NeuroImmunoModulation is 8801. According to SCImago Journal Rank (SJR), this journal is ranked 0.653. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of NeuroImmunoModulation by Year


Year SJR
2025/2026 Coming Soon
2024 0.653
2023 0.6
2022 0.663
2021 0.548
2020 0.635
2019 0.488
2018 0.530
2017 1.064
2016 1.060
2015 0.878
2014 0.735

Ranking of NeuroImmunoModulation by Year


Year Ranking
2025/2026 Coming Soon
2024 8801
2023 8947
2022 7623
2021 9138
2020 7943
2019 10009
2018 9058
2017 4005
2016 4052
2015 5261
2014 6316

NeuroImmunoModulation Publisher


Table Setting

NeuroImmunoModulation is published by S. Karger AG. It's publishing house is located in Switzerland. Coverage history of this journal is as following: 1994-2002, 2004-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of NeuroImmunoModulation is NeuroImmunoModulation. This abbreviation ('NeuroImmunoModulation') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in NeuroImmunoModulation


If your research field is/are related to Endocrine and Autonomic Systems (Q3); Endocrinology (Q3); Immunology (Q3); Neurology (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the NeuroImmunoModulation?

NeuroImmunoModulation latest impact IF is 2.19. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.18 (2016) and 1.56 (2019), respectively, in the last 11 years. Moreover, its average IS is 2.31 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the NeuroImmunoModulation?

The NeuroImmunoModulation has an SJR (SCImago Journal Rank) of 0.653, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.064 in 2017 and the lowest being 0.488 in 2019. Furthermore, the average SJR of the NeuroImmunoModulation over the previous 11-year period stands at 2.31.


What's the latest h-index of the NeuroImmunoModulation?

The latest h-index of the NeuroImmunoModulation is 76.


Who's the publisher of the NeuroImmunoModulation?

The NeuroImmunoModulation is published by the S. Karger AG, with its country of publication being the Switzerland.


What's the current ranking of the NeuroImmunoModulation?

The NeuroImmunoModulation is currently ranked 8801 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 4005 in 2017 and its lowest position of 10009 in 2019.


What's the abbreviation or short name for the NeuroImmunoModulation?

The standard ISO4 abbreviation for the NeuroImmunoModulation is NeuroImmunoModulation.


Is the "NeuroImmunoModulation" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

NeuroImmunoModulation is classified as a journal that the S. Karger AG publishes.


What's the scope or major areas of the NeuroImmunoModulation?

The NeuroImmunoModulation encompasses the following areas:

  • Endocrine and Autonomic Systems
  • Endocrinology
  • Immunology
  • Neurology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the NeuroImmunoModulation?

The NeuroImmunoModulation is assigned the following International Standard Serial Numbers (ISSN): 14230216, 10217401.


What's the best quartile of the NeuroImmunoModulation?

The best quartile for the NeuroImmunoModulation is Q3 (2024).


What's the coverage history of the NeuroImmunoModulation?

The NeuroImmunoModulation coverage history can be summarized as follows: 1994-2002, 2004-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Economics and Management journal 9811 Vilnius Gediminas Technical University 55 2.84
Proceedings of the ASME Turbo Expo conference and proceedings 17577 54 0.00
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Criminal Justice Review journal 10284 SAGE Publications Inc. 46 1.91
Marine Biology Research journal 14618 Taylor and Francis Ltd. 47 1.21
Socialism and Democracy journal 27160 Taylor and Francis Ltd. 19 0.20
Transnational Corporations journal 13970 UNCTAD United Nations Conference on Trade and Development 30 1.63
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29
Natural Solutions trade journal 28581 Innovision Health Media 1 0.00
Indian Phytopathology journal 16772 Springer 20 0.91

Check complete list




Year wise Impact Score (IS) of NeuroImmunoModulation

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 2.19
2023 2.38
2022 2.53
2021 3.06
2020 2.47
2019 1.56
2018 1.77
2017 1.84
2016 3.18
2015 2.31
2014 2.12



Top Journals/Conferences in Endocrine and Autonomic Systems

Brain, Behavior, and Immunity
Academic Press Inc. | United States

Frontiers in Neuroendocrinology
Academic Press Inc. | United States

Neurobiology of Stress
Elsevier Inc. | United States

Psychoneuroendocrinology
Elsevier Ltd | United Kingdom

Journal of Neuroendocrinology
Wiley-Blackwell Publishing Ltd | United Kingdom

Neurogastroenterology and Motility
Wiley-Blackwell Publishing Ltd | United Kingdom

Psychophysiology
John Wiley and Sons Inc | United States

Autonomic Neuroscience: Basic and Clinical
Elsevier B.V. | Netherlands

Clinical Autonomic Research
Springer Science and Business Media Deutschland GmbH | Germany

Neuroendocrinology
S. Karger AG | Switzerland

See All

Top Journals/Conferences in Endocrinology

Lancet Diabetes and Endocrinology,The
Elsevier Ltd | United Kingdom

Endocrine Reviews
The Endocrine Society | United States

Nature Reviews Endocrinology
Nature Publishing Group | United Kingdom

Nature Metabolism
Springer Berlin | Germany

Diabetes Care
American Diabetes Association Inc. | United States

Bone Research
Nature Publishing Group | United Kingdom

Endocrine Pathology
Springer | United States

Diabetologia
Springer Science and Business Media Deutschland GmbH | Germany

Diabetes Technology and Therapeutics
Mary Ann Liebert Inc. | United States

Metabolism: Clinical and Experimental
W.B. Saunders | United States

See All

Top Journals/Conferences in Immunology

Nature Reviews Immunology
Nature Research | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Nature Reviews Microbiology
Nature Research | United Kingdom

Immunity
Cell Press | United States

Nature Immunology
Nature Research | United Kingdom

Science immunology
American Association for the Advancement of Science | United States

Cell Host and Microbe
Cell Press | United States

Nature Microbiology
Nature Research | United Kingdom

Cellular and Molecular Immunology
Springer Nature | United Kingdom

Journal of Experimental Medicine
Rockefeller University Press | United States

See All

Top Journals/Conferences in Neurology

Lancet Neurology, The
Elsevier Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Research | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd | United Kingdom

Brain
Oxford University Press | United Kingdom

Acta Neuropathologica
Springer Science and Business Media Deutschland GmbH | Germany

Ageing Research Reviews
Elsevier Ireland Ltd | Ireland

Sleep Medicine Reviews
W.B. Saunders Ltd | United Kingdom

Translational Neurodegeneration
BioMed Central Ltd | United Kingdom

See All